Hangzhou Deshi Targets HK$900M IPO in Booming Hong Kong Market

Hangzhou Deshi Taps 537% IPO Surge for HK$900M Listing

Hangzhou Deshi Biotechnology has announced plans for a Hong Kong initial public offering to raise up to HK$899.9 million, or approximately $115 million. According to a filing with the Hong Kong Stock Exchange, the company will issue about 8 million shares at a price range of HK$95.6 to HK$112.5 per share. Trading is scheduled to commence on March 30, providing the biotech firm with significant capital for research, development, and expansion.

This move positions Hangzhou Deshi to capitalize on a remarkably buoyant IPO environment. The offering is a clear indicator of corporate confidence in the Hong Kong market, leveraging intense investor interest in the healthcare sector to secure growth funding.

Healthcare and Tech Drive Record HK$97B in 2026 Listings

Hangzhou Deshi's IPO is not an isolated event but a prime example of a wider trend. The Hong Kong IPO market has accelerated dramatically since the start of 2026, with total funds raised climbing 537.34% year-on-year to HK$97.16 billion. So far this year, 28 companies have completed IPOs, a 133% increase from the same period last year, with another 377 firms in the pipeline.

The surge is predominantly fueled by companies in the information technology and healthcare sectors, which are reshaping the market's composition. Dual listings from the mainland have also become a major feature, with 13 A-share companies raising 64.4% of the total IPO funds in Hong Kong this year. Analysts attribute this acceleration to deepening market connectivity and attractive valuations in Hong Kong compared to other exchanges.

HKEX Reforms Signal More Accommodative Listing Environment

Underpinning the IPO boom is a strategic push by regulators to enhance the market's appeal. Hong Kong Exchanges and Clearing (HKEX) recently proposed reforms to lower the listing bar, particularly for high-growth, innovative companies with weighted voting rights (WVR) structures. Key proposals include halving the minimum valuation requirement for WVR companies to HK$20 billion and reducing the revenue threshold from HK$1 billion to HK$600 million.

These proposed changes are designed to attract a new wave of high-quality companies and solidify Hong Kong's status as a premier global listing venue. For firms like Hangzhou Deshi, this evolving regulatory landscape creates a more favorable and competitive environment for raising capital and expanding their international footprint.